This relatively recent recognition represents a paradigm shift where the outcomes of methodologically sound research in humans, with and without diabetes, have in many cases refuted long-established dogma
M., Crispie, F., Kilcawley, K., OSullivan, O., OSullivan, M
Data synthesis We conducted meta-analyses when at least two studies reported relevant outcome data
In 2024, the FDA announced it was evaluating reports of suicidal thoughts and actions in patients taking GLP-1 receptor agonists, though the investigation has not established a definitive causal relationship
3,4 Furthermore, GLP-1R agonists have multiple biological effects that can treat obesity, cardiovascular, neurological, metabolic diseases and play a positive role in tumor therapy
Dallas, TX Verified Purchase "My doctor had me on Mounjaro at $900 a month